Comparison between Advance Agrolife IPO and Gujarat Kidney IPO.
Advance Agrolife IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gujarat Kidney IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Advance Agrolife IPO is up to ₹192.86 Cr whereas the issue size of the Gujarat Kidney IPO is up to ₹250.80 Cr. The final issue price of Advance Agrolife IPO is ₹100.00 per share and of Gujarat Kidney IPO is ₹114.00 per share.
| Advance Agrolife IPO | Gujarat Kidney IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹95.00 per share | ₹108.00 per share |
| Issue Price (Upper) | ₹100.00 per share | ₹114.00 per share |
| Issue Price (Final) | ₹100.00 per share | ₹114.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹5.00 per share | |
| Market Lot Size | 150 shares | 128 shares |
| Fresh Issue Size | 1,92,85,720 shares | 2,20,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹192.86 Cr | up to ₹250.80 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,92,85,720 shares | 2,20,00,000 shares |
| Issue Size Total (Amount) | up to ₹192.86 Cr | up to ₹250.80 Cr |
Advance Agrolife IPO opens on Sep 30, 2025, while Gujarat Kidney IPO opens on Dec 22, 2025. The closing date of Advance Agrolife IPO and Gujarat Kidney IPO is Oct 03, 2025, and Dec 24, 2025, respectively.
| Advance Agrolife IPO | Gujarat Kidney IPO | |
|---|---|---|
| Anchor Bid Date | Sep 29, 2025 | Dec 19, 2025 |
| Issue Open | Sep 30, 2025 | Dec 22, 2025 |
| Issue Close | Oct 03, 2025 | Dec 24, 2025 |
| Basis Of Allotment (Tentative) | Oct 06, 2025 | Dec 26, 2025 |
| Initiation of Refunds (Tentative) | Oct 07, 2025 | Dec 29, 2025 |
| Credit of Share (Tentative) | Oct 07, 2025 | Dec 29, 2025 |
| Listing date (Tentative) | Oct 08, 2025 | Dec 30, 2025 |
| Anchor Lockin End date 1 | Nov 04, 2025 | Jan 24, 2026 |
| Anchor Lockin End date 2 | Jan 03, 2026 | Mar 25, 2026 |
Advance Agrolife IPO P/E ratio is 17.55, as compared to Gujarat Kidney IPO P/E ratio of 61.62.
| Advance Agrolife IPO | Gujarat Kidney IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Advance Agrolife Ltd.'s revenue increased by 10% and profit after tax (PAT) rose by 4% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Gujarat Kidney & Super Speciality Ltd.'s revenue increased by 637% and profit after tax (PAT) rose by 454% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.84 | 99.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.89 | 71.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.55 | 61.62 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹642.86 Cr. | ₹898.81 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 25.42% | 36.61% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.02% | 37.65% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.80 | 0.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.70 | ₹1.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 29.11% | 36.61% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Advance Agrolife IPO Retail Individual Investors (RII) are offered 67,39,502 shares while in Gujarat Kidney IPO retail investors are offered 67,39,502 shares. Qualified Institutional Buyers (QIB) are offered 38,51,144 shares in Advance Agrolife IPO and 77,26,880 shares in Gujarat Kidney IPO.
| Advance Agrolife IPO | Gujarat Kidney IPO | |
|---|---|---|
| Anchor Investor Reservation | 57,76,716 shares | 87,73,120 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 38,51,144 shares | 77,26,880 shares |
| NII | 28,88,358 shares | 33,00,000 shares |
| RII | 67,39,502 shares | 22,00,000 shares |
| Employee | 30,000 shares | 0 shares |
| Others | ||
| Total | 1,92,85,720 shares | 2,20,00,000 shares |
Advance Agrolife IPO subscribed 56.90x in total, whereas Gujarat Kidney IPO subscribed 5.21x.
| Advance Agrolife IPO | Gujarat Kidney IPO | |
|---|---|---|
| QIB (times) | 27.31x | 1.06x |
| NII (times) | 175.30x | 5.73x |
| Big NII (times) | 202.06x | 5.25x |
| Small NII (times) | 121.77x | 6.68x |
| RII (times) | 23.14x | 19.04x |
| Employee (times) | 38.42x | |
| Other (times) | ||
| Total (times) | 56.90x | 5.21x |
